Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

Study assesses impact of anti-SARS-CoV-2 convalescent plasma in COVID-19 disease

The current COVID-19 pandemic is still very much active in most parts of the world. In the absence of effective antiviral drugs or vaccines, scientists are studying the use of blood plasma from convalescent COVID-19 patients, banking on its neutralizing antibody content.